Kynam Capital Management, LP Natera, Inc. Transaction History
Kynam Capital Management, LP
- $953 Million
- Q1 2024
A detailed history of Kynam Capital Management, LP transactions in Natera, Inc. stock. As of the latest transaction made, Kynam Capital Management, LP holds 2,000,000 shares of NTRA stock, worth $213 Million. This represents 19.2% of its overall portfolio holdings.
Number of Shares
2,000,000
Previous 2,400,000
16.67%
Holding current value
$213 Million
Previous $150 Million
21.67%
% of portfolio
19.2%
Previous 16.82%
Shares
9 transactions
Others Institutions Holding NTRA
# of Institutions
439Shares Held
117MCall Options Held
254KPut Options Held
263K-
Vanguard Group Inc Valley Forge, PA11MShares$1.18 Billion0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY7.36MShares$784 Million0.06% of portfolio
-
Fred Alger Management, LLC New York, NY6.55MShares$697 Million3.03% of portfolio
-
Black Rock Inc. New York, NY6.49MShares$691 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.93MShares$418 Million1.68% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $10.3B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...